BOK Financial’s HOOKIPA Pharma HOOK Stock Holding History

BOK Financial’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8	Closed	-$9	–	1224
2025 Q1	$9	Hold	8	–	–	﹤0.01%	1280
2024 Q4	$17	Hold	8	–	–	﹤0.01%	1294
2024 Q3	$33	Buy	+8	New	+$42	﹤0.01%	1359

Other funds holding HOOK

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BOK Financial's HOOK Position: Q2 2025 in Review

BOK Financial sold out of HOOKIPA Pharma (HOOK) in Q2 2025, closing a stake of 8 shares — an estimated $9 sold.

BOK Financial first reported a position in HOOK in Q3 2024 and held it in 3 quarters. The position peaked at $33 in Q3 2024. 27 funds tracked by Wall St. Rank hold HOOK as of Q2 2025.

BOK Financial reported no remaining HOOKIPA Pharma position as of Q2 2025 after selling out during the quarter.
BOK Financial sold 8 HOOKIPA Pharma shares in Q2 2025, an estimated $9.
BOK Financial first reported a position in HOOKIPA Pharma in Q3 2024 and held it in 3 quarters.
BOK Financial's HOOKIPA Pharma position peaked at $33 in Q3 2024.
27 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2025.

Based on BOK Financial's 13F filing for Q2 2025, filed 12 Aug 2025.